Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00903396 · OUTCOME

Tolerability and Adverse Events as Assessed by NCI CTC v 3.0

Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer · Source last updated 2017-11-24

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
Not reported
Unit
Not reported
Interval / dispersion
Not reported
Time frame
Up to 2 years

Analysis population: Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.

Groups in this outcome

Arm I

Patients receive palonosetron hydrochloride IV on day 1. palonosetron hydrochloride: Given IV

Arm II

Patients receive palonosetron hydrochloride IV on days 1 and 4. palonosetron hydrochloride: Given IV

Arm III

Patients receive placebo IV on day 1. placebo: Given IV

Arm IV

Patients receive placebo IV on days 1 and 4. placebo: Given IV

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Arm I0
Arm II0
Arm III0
Arm IV0

Reported measurements

No numerical measurement classes were posted for this outcome. Missing is not zero.

Complete source fields
denoms
  1. counts
    1. group Id
      OG000
      value
      0
    2. group Id
      OG001
      value
      0
    3. group Id
      OG002
      value
      0
    4. group Id
      OG003
      value
      0
    units
    Participants
groups
  1. description
    Patients receive palonosetron hydrochloride IV on day 1. palonosetron hydrochloride: Given IV
    id
    OG000
    title
    Arm I
  2. description
    Patients receive palonosetron hydrochloride IV on days 1 and 4. palonosetron hydrochloride: Given IV
    id
    OG001
    title
    Arm II
  3. description
    Patients receive placebo IV on day 1. placebo: Given IV
    id
    OG002
    title
    Arm III
  4. description
    Patients receive placebo IV on days 1 and 4. placebo: Given IV
    id
    OG003
    title
    Arm IV
population Description
Not enough patients were accrued. In order to avoid identification of patients, no results will be entered.
reporting Status
POSTED
time Frame
Up to 2 years
title
Tolerability and Adverse Events as Assessed by NCI CTC v 3.0
type
SECONDARY

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice